http://purl.org/np/RAhWmxcBRT... RAhWmxcBRT

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

Leoni Bücken

2021-07-03T11:13:55.536Z

http://purl.org/np/RAhWmxcBRT... RAhWmxcBRT

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

equetro is a mood stabilizer indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder 1 1 indicated for the treatment of the pain associated with trigeminal neuralgia 1 2 an anti epileptic drug aed indicated for the treatment of partial seizures with complex symptomatology generalized tonic clonic seizures and mixed seizures 1 3 equetro is indicated for treatment of patients with acute manic or mixed episodes associated with bipolar i disorder see clinical studies 14 1 equetro is indicated in the treatment of the pain associated with trigeminal neuralgia beneficial results have also been reported in glossopharyngeal neuralgia this drug is not a simple analgesic and should not be used for the relief of trivial aches or pains equetro is indicated for the treatment of partial seizures with complex symptomatology e g psychomotor temporal lobe generalized tonic clonic seizures grand mal and mixed seizure patterns which include the seizure types listed here or other partial or generalized seizures limitations of usage equetro is not indicated for the treatment of absence seizures petit mal carbamazepine has been associated with increased frequency of generalized convulsions in these patients

Leoni Bücken

2021-07-03T11:13:55.536Z

http://purl.org/np/RAhWmxcBRT... RAhWmxcBRT

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/DOID_12098 DOID_12098

Leoni Bücken

2021-07-03T11:13:55.536Z

http://purl.org/np/RAhWmxcBRT... RAhWmxcBRT

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

Leoni Bücken

2021-07-03T11:13:55.536Z

http://purl.org/np/RAhWmxcBRT... RAhWmxcBRT

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/drugbank:DB00564 drugbank:DB00564

Leoni Bücken

2021-07-03T11:13:55.536Z

http://purl.org/np/RAhWmxcBRT... RAhWmxcBRT

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/association_type association_type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

Leoni Bücken

2021-07-03T11:13:55.536Z

http://purl.org/np/RAhWmxcBRT... RAhWmxcBRT

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

Leoni Bücken

2021-07-03T11:13:55.536Z

http://purl.org/np/RAhWmxcBRT... RAhWmxcBRT

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://w3id.org/um/neurodkg/SymptomaticReliefIndication SymptomaticReliefIndication

Leoni Bücken

2021-07-03T11:13:55.536Z